4//SEC Filing
Schwab Gisela 4
Accession 0000939767-21-000043
CIK 0000939767other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 8:10 PM ET
Size
9.6 KB
Accession
0000939767-21-000043
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Schwab Gisela
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Option (right to buy)
2021-04-26−50,000→ 0 totalExercise: $1.70From: 2015-07-20Exp: 2021-09-18→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2021-04-26$1.70/sh+50,000$85,000→ 663,482 total - Sale
Common Stock
2021-04-26$25.00/sh−50,000$1,250,000→ 613,482 total
Holdings
- 14,880(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021.
- [F3]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of April 26, 2021.
- [F4]The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016.
Documents
Issuer
EXELIXIS, INC.
CIK 0000939767
Entity typeother
Related Parties
1- filerCIK 0001213140
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 8:10 PM ET
- Size
- 9.6 KB